We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 29, 2021

SGLT2 Inhibitors and Retinal Vein Occlusion Risk in T2D

Diabetes Care


Additional Info

Diabetes Care
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study
Diabetes Care 2021 Jul 22;[EPub Ahead of Print], MK Lee, B Kim, K Han, JH Lee, M Kim, MK Kim, KH Baek, KH Song, HS Kwon, YJ Roh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading